FDA Import Refusal 1FX-8049552-6/10002/1 — MITSUBISHI TANABE PHARMA CORPORATION .
The FDA refused shipment 1FX-8049552-6/10002/1 from MITSUBISHI TANABE PHARMA CORPORATION . (Japan) on Aug 19, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Aug 19, 2026
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75